Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jul 12, 2011 (rev. 1)

Premium

23andMe has appointed Ashley Ledbetter Dombkowski to chief business officer. She was previously a member of the board of directors and will report to CEO Anne Wojcicki.

Dombkowski joins 23andMe after 11 years at MPM Capital where she served as managing director and a member of the firm's investment committee. Prior to MPM she was a healthcare analyst at Tiger Management and Dresdner RCM Global Investors. She holds a PhD in mathematics from Rice University and a BA in mathematics from Wellesley College.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.